Macula Society Research Grant

The purpose of the MSRG program is to provide funding for clinically relevant research into macular or retinal vascular diseases. Pilot projects with the potential to obtain additional external funding and projects coordinating the efforts of the general membership are preferred. Projects that already receive or are expected to receive $50,000 or more from other sources are not eligible for the Macula Society Research Grant Program. Members who received a research grant in the past three years are not eligible.

2018-2019 Research Grant Application

All files uploaded must be PDF format.
Deadline: November 15, 2018 at 5 PM EST.
Click here for past recipients of a Retina Research Foundation grant who are also ineligible to apply for the MSRG.
Research Grant Overview 
  1. We have three separate grants per year available to support research endeavors of the members of the Macula Society. Retina Research Foundation supports one grant of $30k and Regeneron supports two grants of $37,500K. The funding of a proposal will be determined by the Research Committee depending on several criteria based upon(i) the project design (ii) the project feasibility (iii) the project significance. The ranking will then be presented to the Executive Committee and distribution of the final funding determined. 
  1. The due date for applications will be November 15, 2018 at 5 PM EST on the Macula Society web site. These should be submitted on line to allow easy transmittal to the various research committee members. The Macula Society Office will then disseminate the received applications to Committee members who will evaluate and rank them and make recommendations to the Chair for funding. These summaries will then be returned both to the Chair and Society secretary who will tally these numerical scores from which the final recommendations will be made. The funds will be released and the winner will be announced at the time of the 2019 Annual Meeting. 
  1. No member of the Executive Committee or Research Committee may apply for this award during their time of service. 
  1. Due to monetary restrictions, past Retina Research Foundation Award recipients are ineligible for this award. Click here for past recipients of a Retina Research Foundation grant who are ineligible to apply for the MSRG, or you may review the list on the Research Foundation site, http://retinaresearchfnd.org/research-programs/awardhistory/ 
 Funding Guidelines: 
  1. The proposed research must have the potential of increasing the understanding of macular or retinal diseases. Grant proposals facilitating collaboration among the Macula Society members to study a particular disease are encouraged as well. Research receiving partial funding from sources additional to this MSRG award is also eligible, as the Macula Society believes that their support may encourage others to fund research. 
  1. Funds are to be applied to equipment, supplies, and non-physician salary support. 
  1. Research must conform to accepted standards of conduct (e.g., ARVO Guidelines for Use of Animals in Research), and is to receive institutional approval by the appropriate review committees (e.g., Animal Care Committee, Human Research Review Committee, etc.). 
  1. The duration of the research project must not exceed 18 months. Research monies not disbursed during this time will be returned to the Macula Society. 
  1. The firm deadline for receipt of an application is listed above. All applications must be submitted online through the Macula Society web site, www.maculasociety.org. 
  1. Members of the Grant Application Review Committee consist of the Macula Society Research and Education Committee, who, as members, are ineligible for consideration of these awards. Members of the Executive Committee are also ineligible for consideration. 
  1. Award recipients must acknowledge the support of the Macula Society Research Award Grant Program on all papers, presentations, and abstracts regarding the supported research. 
  1. Each recipient must present their research project to the Macula Society within two years of receiving an award. The presentation will be given in a specially designated section of the Annual Meeting of the Macula Society. 
  1. An audit of funds may be requested by the Macula Society at the completion of the project. 
Macula Society Research Committee
c/o Stacy Singerman
3401 Enterprise Parkway, Suite 310
Beachwood, Ohio 44122
Phone: 216.839.4949 Fax: 216.831.8221

Research Grant Application

    Research Grant Recipients

    2018

    The Mills and Margaret Cox Macula Society Research Project
    $30,000
    Cagri G. Besirli; MD, PhD
    Department of Ophthalmology and Visual Sciences, University of Michigan
    Title: The Role of HK2 in Photoreceptor Metabolism and Survival
     
    The Macula Society Research Grant supported by Regeneron
    $37,500
    Shlomit Schaal MD
    UMASS Medical School
    Title: Cone Photoeceptor defects in Retinal Degenerative Diseases
     
    The Macula Society Research Grant supported by Regeneron
    $37,500
    Naresh Mandava MD
    University of Colorado
    Title: Protein Biomarkers and Biological Pathways in the Recticular Pseudodrusen Phenotype of Age-Related Macular Degeneration

    2017

    M.E. Hartnett
    Novel Gene Therapy to Regulate Pathologic Neovascularization in AMD

    2016

    Christine A. Curcio, PhD
    Visualizing organelles in human retinal pigment epithelium by 3-dimensional electron microscopy

    2015

    Robyn Heather Guymer, MD
    The role of reduced phagocytosis in the pathogenesis of AMD

    2013

    Demetrios Vavvas, MD
    Role of RIP3 Kinase in Inflammation and Photoreceptor Cell Loss

    2012

    Kang Zhang, M.D.
    Using AMD Patient iPSCs for RPE Differentiation and Disease Modeling

    Amani Fawzi, M.D.
    Platform for long-term Delivery of Anti-Angiogenic Peptides for Intravitreal Treatment of Neovascular Eye Disease

    Milam A. Brantley, Jr., M.D., PhD.
    Small molecule-mediated differential expression of HTRA1 and ARMS2 to elucidate gene function in AMD

    2011

    Stephen Tsang, MD, PhD
    Genetic and Environmental Factors in AMD

    Click here for a link to the report on youtube.

    tsang

    Stephen Jae Kim, MD
    Safety, Pharmacokinetics, and Efficacy of Celecoxib and Valdecoxib after Intraocular Administration for Macular Edema

    kim

    2010

    J. William Harbour, MD
    Development of a blood test to diagnose uveal melanoma

    harbour

    2009

    Rajendra S. Apte, MD
    Wnt Signaling in Choroidal Neovascularization

    Apte

    Lloyd P. Aiello, MD
    Treatment with Oral Rosiglitazone to Prevent the Progression of Diabetic Retinopathy in eyes at high risk of developing proliferative disease

    AIELLO

    2007

    Paul Sternberg, MD
    Plasma proinflammatory biomarkers in patients with age-related macular degeneration

    sternberg

    Jose Pulido, MD
    Activation State fo Immune Cells in the Human Choriod

    PULIDOJOSE

    Member Login

    Officers

    President
    H. Richard McDonald, MD

    President-Elect
    Joan W. Miller, MD

    Secretary
    Carol L. Shields, MD

    Treasurer
    Mark W. Johnson, MD

    Executive Secretary
    Lawrence J.  Singerman, MD

    Established 1977
    Lawrence Singerman - Founder

    Committee Chairs

    Awards
    Andrew P. Schachat, MD

    By-Laws Chair
    Christina J. Flaxel, MD

    Credentials
    Glenn J. Jaffe, MD

    Meeting Planning
    Peter K. Kaiser, MD

    Nominating
    Jennifer I. Lim, MD

    Program
    Srini Vas Sadda, MD

    Research & Education
    David N. Zacks, MD

    Website
    Demetrios G. Vavvas, MD

    AAO Representative
    Sharon D. Solomon, MD

    International Representative
    Tien Y. Wong, MD

    Young Member
    Elliot H. Sohn, MD

    Past Presidents

    Arnall Patz, MD
    J. Donald M. Gass, MD
    Morton F. Goldberg, MD
    Robert C. Watzke, MD
    Stephen J. Ryan, MD
    John G. Clarkson, MD
    David H. Orth, MD
    Alexander J. Brucker, MD
    Lee M. Jampol, MD
    Thomas M. Aaberg, MD
    Travis A. Meredith, MD
    Kurt A. Gitter, MD
    William F. Mieler, MD
    Daniel Finkelstein, MD
    Lawrence A. Yannuzzi, MD
    Evangelos S. Gragoudas, MD
    Jerry A. Shields, MD
    Michael L. Klein, MD
    Emily Y. Chew, MD
    Mark S. Blumenkranz, MD
    Neil M. Bressler, MD
    Paul Sternberg, Jr., MD
    Gil Grand, MD
    Andrew P. Schachat, MD
    James C. Folk, MD

    Conference Management Software by X-CD Technologies Inc.